The CEO of mental health startup Cerebral stepped down in December 2024, Endpoints News has learned.
GSK, Amgen and AstraZeneca released positive data supporting their rival drugs in a condition called chronic rhinosinusitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback